Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
L. Nersisyan, H. Wurth, A. Gevorgyan, H. Binder, A. Arakelyan (Yereven, Armenia; Leipzig, Germany). Methylation associated pathway activity deregulation in lung adenocarcinoma. Eur Respir J 2014; 44: Suppl. 58, 403

Member's Comments

No comment yet.

Related content which might interest you: Surface expression of CTLA-4 on CD4/CD25high cells in lung cancer Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 Surface vs. intracellular CTLA-4 expression in lung cancer Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 Telomere-associated gene network in lung adenocarcinoma Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey Year: 2015 The methylation profiling of multiple tumor suppressor genes in plasma cell-free DNA from patients with NSCLC versus non-malignant tumors - pilot study Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 High-throughput detection of alternative splicing in patients with non-small cell lung cancer treated by bevacizumab/erlotinib Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer Year: 2014 Role of hypoxia in epithelial-to-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level? Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Gene expression of EGFR, MINA53,MEN1 and MTOR in NSCLCs Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Expression analysis of miR-21 in Bulgarian patients with non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 The phenotypes and serum levels of alpha-1 antitrypsin in lung cancer patients – Preliminary results Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 Molecular profiling of lung squamous carcinogenesis Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Expression and clinical implications of the estrogen receptor β in lung adenocarcinoma Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Prevalence of molecular changes in resected pulmonary adenocarcinomas Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 SMYD3 links lysine methylation of MAP3K2 to ras-driven lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 A requirement for IKKa in lung adenocarcinoma Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Mining common pathway deregulation profiles in lung diseases Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD) Year: 2014 Polymorphism of HLA-G gene promotor in patients with non small cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Investigation of survivin gene expression in non small cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Comprehensive evaluation of nuclear factor-κΒ expression patterns in non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 LATE-BREAKING ABSTRACT: Decreased sirtuin expression in squamous cell carcinoma compared to adenocarcinoma Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014